Laboratory of Healthcare Associated Infection, Microbiological Services Colindale, Health Protection Agency, London, UK.
J Hosp Infect. 2011 Nov;79(3):260-4. doi: 10.1016/j.jhin.2011.07.008. Epub 2011 Sep 8.
Healthcare-associated infection (HCAI) and related problems of antimicrobial resistance (AMR) place a considerable burden on healthcare delivery, patients, their families and carers, and the economy. Once considered a low priority, they are now recognized globally as major patient safety issues. The European Union's Directorate General for Health and Consumer Protection released a public consultation on strategies for improving patient safety by the prevention and control of HCAI, and increased standards of antimicrobial stewardship. They also specified that the 'Improving Patient Safety in Europe' research project they had funded would develop consensus standards and related performance indicators (SPIs) for the prevention and control of HCAI and AMR. This article describes how consensus was reached between 29 participating European countries, the detailed SPIs, and a reduced set of indicators ('13+13') that could be used internationally and nationally to stimulate and review improvement in HCAI prevention and control, and antimicrobial stewardship activities.
医疗保健相关感染（HAI）和相关的抗生素耐药问题（AMR）给医疗服务、患者、患者家属和照护者以及经济带来了相当大的负担。这些问题曾经被认为是低优先级的，但现在已经被全球公认为主要的患者安全问题。欧盟卫生和消费者保护总局发布了一项公开咨询，内容涉及通过预防和控制 HAI 以及提高抗生素管理标准来改善患者安全的策略。他们还特别指出，他们资助的“改善欧洲患者安全”研究项目将制定预防和控制 HAI 和 AMR 的共识标准和相关绩效指标（SPI）。本文描述了如何在 29 个参与的欧洲国家之间达成共识，详细的 SPI，以及一组减少的指标（“13+13”），这些指标可以在国际和国家层面上用于刺激和审查 HAI 预防和控制以及抗生素管理活动的改进。
